C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/18 (2006.01) A61K 38/18 (2006.01) C07K 14/71 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2191071
Disclosed is an altered, soluble form of the FLT polypeptide being capable of binding to VEGF and thereby exerting an inhibitory effect thereon, the polypeptide comprising five or fewer complete immunoglobulin-like domains, together with pharmaceutical compositions comprising the polypeptide, and various uses thereof.
On décrit une forme soluble modifiée du polypeptide du récepteur de la tyrosine kinase (FLT), capable de se lier au facteur de croissance de cellules endothéliales vasculaires (VEGF) et d'exercer ainsi un effet inhibiteur sur celui-ci, ce polypeptide comprenant au maximum cinq domaines complets de type immunoglobuline. On décrit également les compositions pharmaceutiques comprenant ce polypeptide ainsi que diverses utilisations de celui-ci.
Boocock Christine Anne
Charnock-Jones David Stephen
Sharkey Andrew Mark
Smith Stephen Kevin
Kirby Eades Gale Baker
Metris Therapeutics Limited
LandOfFree
Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1442023